Drug General Information (ID: DDIFT38IYK)
  Drug Name Pemetrexed Drug Info Cefuroxime Drug Info
  Drug Type Small molecule Small molecule
  Therapeutic Class Antineoplastics Antibiotics
  Structure

 Mechanism of Pemetrexed-Cefuroxime Interaction (Severity Level: Moderate)
     Competitive inhibition of renal tubular secretion Click to Show/Hide Mechanism Graph
Could Not Find 2D Structure
      Drug Name Pemetrexed Cefuroxime
      Mechanism Pemetrexed Competitive inhibition of renal tubular secretion of pemetrexed
      Key Mechanism Factor 1
Factor Name Renal tubular secretion
Factor Description Renal tubular secretion allows selective transfer of substances from the blood around the capillaries into the renal tubules via filtrate. Drug excretion may be reduced when two drugs compete for renal tubular secretion.
      Mechanism Description
  • Decreased elimination of Pemetrexed caused by Cefuroxime mediated competitive inhibition of renal tubular secretion

Recommended Action
      Management Patients receiving pemetrexed in combination with other drugs that undergo active tubular secretion should be monitored for excessive pharmacologic effects of one or both drugs, and the dosages of the drugs adjusted if necessary. The potential for increased toxicity of pemetrexed such as bone marrow suppression should be considered. Renal function should be closely monitored during therapy.

References
1 Product Information. Alimta (pemetrexed). Lilly, Eli and Company, Indianapolis, IN.